Phase II trial of famotidine/omeprazole in patients with gastro-oesophageal reflux disease.
Phase of Trial: Phase II
Latest Information Update: 22 Oct 2008
At a glance
- Drugs Famotidine/omeprazole (Primary) ; Famotidine; Omeprazole
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- Sponsors Orexo
- 03 Apr 2008 New trial record.
- 27 Mar 2008 Results have been reported in an Orexo media release.